There are many ongoing cases against Merck, the manufacturer of Januvia, over severe side effects associated with the drug. In the past few years, a number of studies have come out showing that Type II Diabetes drugs such as Januvia increase an individuals risk of developing Pancreatitis, Pancreatic cancer, and Thyroid cancer among other side effects, and the FDA has issued numerous drug safety communications relating to Januvia and other drugs in its class. Currently, Merck is not offering any Januvia settlements; however, this could change as the litigation against the company proceeds.
Januvuia settlement potential
It is difficult to say how likely Januvia settlements will be, but the large number of cases and the huge attention that has been paid to these drugs and the potentially lethal side effects could indicate the the manufacturers would be willing to agree to settlements. As the cases pending against the Merck make their way through the legal system, it will be easier to determine how likely settlements will be and how much the settlements will be for.
One sign pointing to the potential scope of the problem is the fact that 53 different cases representing 4 different drugs in the incretin mimetic class have been merged into one Multi-District Litigation case. It is highly unusual to have multiple drugs and multiple manufacturers subject of one MDL case.
Currently, the majority of the cases against the manufacturers of incretin mimetics are related to the development of pancreatitis and pancreatic cancer after taking the drug. The focus of the most recent studies were related to these issues, and this was the focus when the FDA met with drug manufacturers in June of 2013 to discuss the drugs and whether or not the consequences outweighed the benefits associated with the drugs. Settlements are most likely for cases relating to the development of pancreatic cancer or pancreatitis depending on the results of pending litigation.
Am I eligible for a Januvia Settlement?
Though there is not yet a Januvia settlement, active litigation against Merck is ongoing. If you have developed pancreatitis or pancreatic cancer while on or after taking Januvia, you may be entitled to compensation for your pain and suffering. We encourage you to contact our experienced pharmaceutical litigation specialists for a free consultation to explore your legal rights and see if you have a case. You can contact us toll free by calling 1-800-677-3784 or by using the contact form below.